Tidal Investments’s Amicus Therapeutics FOLD Stock Holding History

Tidal Investments’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52,382	Closed	-$757K	–	2688
2026 Q1	$757K	Buy	52,382 +1,226	+2%	+$17.6K	﹤0.01%	1638
2025 Q4	$728K	Sell	51,156 -2,037	-4%	-$20K	﹤0.01%	1442
2025 Q3	$419K	Sell	53,193 -2,674	-5%	-$19K	﹤0.01%	1656
2025 Q2	$320K	Buy	+55,867	New	+$361K	﹤0.01%	1619

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Tidal Investments's FOLD Position: Q2 2026 in Review

Tidal Investments sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 52,382 shares — an estimated $757K sold.

Tidal Investments first reported a position in FOLD in Q2 2025 and held it in 4 quarters. The position peaked at $757K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Tidal Investments reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Tidal Investments sold 52,382 Amicus Therapeutics shares in Q2 2026, an estimated $757K.
Tidal Investments first reported a position in Amicus Therapeutics in Q2 2025 and held it in 4 quarters.
Tidal Investments's Amicus Therapeutics position peaked at $757K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.